Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D05UXU
|
||||
Former ID |
DIB003462
|
||||
Drug Name |
INM-176
|
||||
Synonyms |
WIN-026; Win-025; Alzheimer's therapeutic, Whanin Pharmaceuticals; KR-WAP-026; Anti-beta amyloid/AChE inhibitor (Alzheimer's), WhanIn; Anti-beta amyloid/acetylcholinesterase inhibitor (Alzheimer's), WhanIn
|
||||
Indication | Alzheimer disease [ICD9: 331; ICD10:G30] | Phase 3 | [523260] | ||
Company |
Scigenic & Scigen Harvest Co Ltd
|
||||
Target and Pathway | |||||
Target(s) | Acetylcholinesterase | Target Info | Inhibitor | [531983] | |
KEGG Pathway | Glycerophospholipid metabolism | ||||
Cholinergic synapse | |||||
Pathway Interaction Database | ATF-2 transcription factor network | ||||
PathWhiz Pathway | Phospholipid Biosynthesis | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.